Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Granuloma, Plasma Cell × brigatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Lymphoma, Large-Cell, Anaplastic 3 Granuloma, Plasma Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

selinexor 1 repotrectinib 1 pazopanib 1 brigatinib 1 Suspensions 1 Proton Therapy 1 Ifosfamide 1 Doxorubicin 1 Capsules 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04925609 2025-12-05

Briga-PED

Princess Maxima Center for Pediatric Oncology

Phase 1/2 Recruiting

LymphoidPlasma cell

Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡